Skip to main content
OpenTrials
Completed

NCT Number: NCT00519753

Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav

The purpose of this study is to assess the safety and efficacy of transitioning uncontrolled glaucoma patients to DuoTrav from other mono or adjunctive therapies.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Mainz

Mainz, DE-55101, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults with primary open-angle glaucoma, ocular hypertension or pigment dispersion glaucoma.
  • Other protocol-defined inclusion criteria may apply.

Exclusion criteria

  • Age related.
  • Other protocol-defined exclusion criteria may apply.

Treatment and study plan

Travoprost 0.004%/timolol maleate 0.5% fixed combination ophthalmic solution (DuoTrav)

Drug

One drop in study eye(s) once daily in the evening (at 8:00 PM) for 12 weeks

Other names: DUOTRAV®

Primary outcomes

  1. Change in intraocular pressure at 12 weeks from travoprost prior therapy (baseline)

    Time frame: Baseline and 12 weeks

Secondary outcomes

  1. Change in intraocular pressure at 12 weeks from other prior therapies (baseline)

    Time frame: 12 weeks

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Official study title

Safety and Efficacy of Switching to the Travoprost/Timolol Maleate Fixed Combination (DUOTRAV®) From Prior Mono or Two-Drug Therapy in Germany

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Aug 23, 2007
Registry last updated
Nov 18, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.